Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
International Journal of Molecular Sciences
|
May 27, 2023
Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence
Beatrice Ragnoli, Beatrice Da Re, Alessandra Galantino, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
September 30, 2025
Cardiac sarcoidosis recurrence post-heart transplant: A critical literature and case report
Andrea Salotti, Lucrezia Mondini, Paola Confalonieri, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 23, 2024
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study
Barbara Ruaro, Andrea Salotti, Nicolò Reccardini, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 27, 2025
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis
Stefano Kette, Nicolò Reccardini, Francesco Salton, et al.
Biomedicines
|
June 26, 2025
Comorbidities' Effect on IPF: Pathogenesis and Management
Andrea Salotti, Maria Chianese, Antonio Romallo, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
International Journal of Molecular Sciences
|
May 27, 2023
Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence
Beatrice Ragnoli, Beatrice Da Re, Alessandra Galantino, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
September 30, 2025
Cardiac sarcoidosis recurrence post-heart transplant: A critical literature and case report
Andrea Salotti, Lucrezia Mondini, Paola Confalonieri, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 23, 2024
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study
Barbara Ruaro, Andrea Salotti, Nicolò Reccardini, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 27, 2025
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis
Stefano Kette, Nicolò Reccardini, Francesco Salton, et al.
Biomedicines
|
June 26, 2025
Comorbidities' Effect on IPF: Pathogenesis and Management
Andrea Salotti, Maria Chianese, Antonio Romallo, et al.
Page
of 1